feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Alabama Power freezes rates

trending

Ukraine peace talks edge forward

trending

Campbell's Soup executive racist remarks

trending

September PPI data release

trending

Alphabet races toward $4 trillion

trending

Farmers Insurance rate hike request

trending

Google stock AI momentum

trending

Richard Branson wife Joan dies

trending

Lake effect snow warning

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Nose Drops Fight Deadly Brain Cancer

Nose Drops Fight Deadly Brain Cancer

24 Nov

•

Summary

  • Nasal drops deliver tumor-fighting medicine to the brain.
  • Method effectively treats glioblastoma by boosting immune response.
  • Technology uses engineered nanostructures called spherical nucleic acids.
Nose Drops Fight Deadly Brain Cancer

A novel approach using nasal drops shows promise for treating aggressive brain cancers, offering a non-invasive alternative to current therapies. Researchers have developed a technology that delivers tumor-fighting medicine directly to the brain through the nose, effectively boosting the immune system's response against glioblastoma in mice.

This new method employs spherical nucleic acids (SNAs), engineered nanostructures that activate the stimulator of interferon genes (STING) pathway. This activation is crucial for 'warming up' cold tumors, which are typically resistant to immunotherapy, thereby enhancing the efficacy of treatments like checkpoint inhibitors.

The development marks a significant step toward more effective and less invasive treatments for glioblastoma. Further studies are ongoing to determine how these findings translate to human patients, offering hope for safer and more potent therapies for brain cancer and other immune-resistant malignancies.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Researchers are using specially engineered nasal drops to deliver tumor-fighting medicine directly to the brain, boosting the immune response against glioblastoma.
SNAs are nanostructures that activate the STING pathway, reprogramming the brain's immune microenvironment to better fight glioblastoma tumors.
The nasal spray technology is currently in development and has shown effectiveness in mice studies; it is not yet consumer-ready for clinical use.

Read more news on

Healthside-arrow

You may also like

Alzheimer's Gene Linked to Delirium: A Dual Brain Threat

19 hours ago • 7 reads

article image

Hidden Fat Fuels Brain Aging, Alzheimer's Risk

1 day ago • 5 reads

article image

Diabetes & MASLD: Power Plants Fail Fuel Switch

19 hours ago • 2 reads

article image

Sonali Bendre's Cancer Claims Spark Doctor Backlash

1 day ago • 4 reads

article image

Rare Brain Cancer Vanquished by Experimental Drugs

23 Nov • 13 reads

article image